ASA and Primary Prevention

Описание к видео ASA and Primary Prevention

The benefits of acetylsalicylic acid (ASA) for secondary prevention of atherosclerotic cardiovascular disease are well established. In contrast, although low-dose ASA therapy for primary prevention of atherosclerotic cardiovascular disease was once commonly recommended, this practice is now being reconsidered in light of recent evidence. Three large randomized controlled trials on primary prevention found no net benefit of ASA for prevention of cardiovascular events or mortality in healthy older adults.  The presentation reviews these and other data on this important clinical issue.

Комментарии

Информация по комментариям в разработке